ArticleNature communications2018

Discovery of Mcl-1-specific inhibitor AZD5991 and preclinical activity in multiple myeloma and acute myeloid leukemia.

Adriana E Tron et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.